NYSE: RMD - ResMed

Yield per half year: +7%
Sector: Healthcare

Share chart ResMed


About

ResMed является калифорнийской компанией по производству медицинского оборудования. В первую очередь это касается оборудования, связанного с лечением нарушений дыхания, связанных со сном, включая апноэ во сне, хроническую обструктивную болезнь легких и другие респираторные заболевания


Main settings

Цена ао 175.86
P/E 43.58
P/S 6.76
P/BV 8.51
EV/EBITDA 22.23
Дивиденд ао 1.92
Див.доход ао 1.17
EBITDA 0.8435
Сайт http://www.resmed.com
Число акций ао 0.14755 млрд
Выручка 2.61
ISIN US7611521078
Change price per day: -4.54% (184.04)
Change price per week: -2.76% (180.66)
Change price per month: -5.73% (186.35)
Change price per 3 month: +17.03% (150.12)
Change price per half year: +7% (164.18)
Change price per year: -20.08% (219.81)
Change price per 3 year: -15.13% (207.01)
Change price per 5 year: +17.02% (150.13)
Change price per year to date: +1.5491% (173)


All parameters ⇨

Grade

Underestimation

Title Value Grade
P/S 6.76 1
P/BV 8.51 1
P/E 43.58 5
EV/EBITDA 22.23 5
Total:

Efficiency

Title Value Grade
ROA, % 15.15 5
ROE, % 23.96 7
Total:

Dividends

Title Value Grade
Div yield, % 1.1526 2
DSI 0.93 9
Total:

Debt

Title Value Grade
Debt/EBITDA 1.1795 8
Total:

Growth impulse

Title Value Grade
Profit growth, % 48.99 10
Share price growth, % 68.85 10
Dividend growth, % 6.44 1
Total:

Dividends

Dividends, % Dividends Result of period Buy before Register closing date Payment before
0.25% 0.48 IV кв. 2023 05.02.2024 07.02.2024 22.02.2024
0.27% 0.48 II кв. 2023 14.08.2023 16.08.2023 31.08.2023
0.18% 0.44 II кв. 2022 15.08.2022 17.08.2022 01.09.2022
0.18% 0.42 IV кв. 2021 07.02.2022 09.02.2022 24.02.2022
0.18% 0.42 III кв. 2021 05.11.2021 09.11.2021 24.11.2021
0.16% 0.42 II кв. 2021 16.08.2021 18.08.2021 02.09.2021
0.18% 0.38 I кв. 2021 10.05.2021 12.05.2021 27.05.2021
0.19% 0.38 IV кв. 2020 08.02.2021 10.02.2021 25.02.2021

Insider trading

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
01.09.2023 07.09.2023 Rider Michael J
Global General Counsel
Sale 161.15 4 029 25 0 0 link
17.07.2023 18.07.2023 Douglas Robert Andrew
President and COO
Sale 222.22 333 330 1500 0 0 link
10.05.2023 12.05.2023 Sandercock Brett
Chief Financial Officer
Sale 233.13 2 931 380 12574 0 -0.01 link
03.05.2023 04.05.2023 PENDARVIS DAVID
Chief Administrative Officer
Sale 237.64 356 460 1500 0 0 link
24.04.2023 25.04.2023 Ghoshal Kaushik
President, SaaS Business
Sale 230 460 000 2000 0 0 link
15.11.2022 16.11.2022 BLAISE LUCILE
President, Sleep & RC Business
Sale 225.18 38 055 169 0 0 link
15.11.2022 16.11.2022 BLAISE LUCILE
President, Sleep & RC Business
Buy 225.18 116 193 516 0 0 link
14.10.2022 17.10.2022 Douglas Robert Andrew
President and COO
Sale 215.09 2 442 350 11355 0 -0.01 link
14.10.2022 17.10.2022 Douglas Robert Andrew
President and COO
Buy 58.24 1 050 240 18033 0 0.01 link
15.09.2022 16.09.2022 Douglas Robert Andrew
President and COO
Sale 232.38 1 394 280 6000 0 0 link
15.09.2022 16.09.2022 Douglas Robert Andrew
President and COO
Sale 232.51 2 601 550 11189 0 -0.01 link
15.09.2022 16.09.2022 Douglas Robert Andrew
President and COO
Buy 58.24 1 050 240 18033 0 0.01 link
15.02.2022 16.02.2022 Farrell Michael J.
Chief Executive Officer
Sale 234.06 1 328 290 5675 0 0 link
15.02.2022 16.02.2022 Farrell Michael J.
Chief Executive Officer
Buy 57.76 327 788 5675 0 0 link
03.02.2022 04.02.2022 PENDARVIS DAVID
Chief Administration Officer
Sale 232.87 359 551 1544 0 0 link
22.11.2021 23.11.2021 Burt Carol
Director
Sale 260 390 000 1500 0 0 link
01.10.2021 01.10.2021 Hollingshead James
President, Sleep Business
Sale 261.33 627 192 2400 0 0 link
20.08.2021 23.08.2021 Sandercock Brett
Chief Financial Officer
Sale 281.73 3 024 650 10736 0 -0.01 link
20.08.2021 23.08.2021 Sandercock Brett
Chief Financial Officer
Buy 57.76 620 111 10736 0 0.01 link
10.05.2021 11.05.2021 Sandercock Brett
Chief Financial Officer
Sale 196 490 000 2500 0 0 link
24.11.2020 25.11.2020 Sandercock Brett
Chief Financial Officer
Sale 211 1 055 000 5000 0 0 link
05.11.2020 13.11.2020 Leong Justin
President, Asia Latin America
Sale 211.36 1 635 930 7740 0 -0.01 link
05.11.2020 13.11.2020 Leong Justin
President, Asia Latin America
Buy 57.76 447 062 7740 0 0.01 link

Main owners

Institutions Volume Share, %
Vanguard Group Inc 17569822 11.95
Blackrock Inc. 12099599 8.23
State Street Corporation 6163455 4.19
FMR, LLC 3811419 2.59
Geode Capital Management, LLC 3388143 2.3
Morgan Stanley 2329618 1.58
Invesco Ltd. 2007085 1.36
Citadel Advisors Llc 1719557 1.17
Northern Trust Corporation 1491269 1.01
Norges Bank Investment Management 1174638 0.8

Contained in ETF

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Michael J. Farrell BE, MBA, SM CEO & Chairman 2.87M 1972 (52 years)

About company

Address: United States, San Diego, CA , 9001 Spectrum Center Boulevard - open in Google maps, open in Yandex maps
Website: http://www.resmed.com
Phone: +858 836 5000